The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani

Promoter sold over 1%Ownership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

—Next day

₹25.99

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%—

Healthcare Service Provider peers, median of 22sector-0.1%—

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

—-0.7—+0.1—

Next day

—-0.7—-0.1—

—-0.2—-0.5—

-0.0-0.1+0.0-2.5+2.5

—+0.4—-1.3—

—+0.3—-2.0—

—+1.0—-1.3—

15d

-12.6-0.2-12.4-1.4-11.2

-12.6-1.2-11.4-5.1-7.5

—+0.6—-4.5—

-26.0-4.3-21.8-12.8-13.2

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Arjan Lalchandani, Promoter and Managing Director of Dr Lalchandani Labs Ltd, sold 76,000 equity shares through open market between August 22 and August 29, 2025. The sale represents 1.75% of the company's total share/voting capital. His holding fell from 12,26,851 shares (28.31%) to 11,50,851 shares (26.56%) post-sale. The disclosure was filed under Regulation 29(2) of SEBI's Takeover Regulations, 2011, and the mode of sale was open market.

Likely market impact

A modest promoter offload of 1.75% via open market; holdings still well below the 50% mark. Retail investors may view this as a mild negative signal, though the stake remains substantial at 26.56%.